lung cancer
Conditions
Interventions
Conventional treatment group: Treated with conventional therapy for 4 months after operation.
NINJIN-YOUEI-TO group: In addition to conventional treatment, Kracie NINJIN-YOUEI-TO Extract Fine Granules
Sponsors
Tanaka Yugo
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Patients over 20 years old with performance status of 0-1 who were diagnosed or suspected with primary lung cancer. 2. Patients undergoing uni-lobectomy with group-2 lymphadenectomy. 3. Patients who consented to the study in writing. 4. Patients scheduled to undergo thoracoscopic surgery including robot-assisted surgery.
Exclusion criteria
Exclusion criteria: 1. Patients who have history of allergies in NINJIN-YOUEI-TO in the past. 2. Patients who were treated with Kampo formulation for this symptom within 2 weeks before the start of this study. 3. Patients who have severe anorexia, nausea and vomiting which are careful administration of this drug. 4. Patients whom the doctor judged unsuitable as the subject. 5. Patients who do not retain liver function and kidney function -Total Bilirubin <=2.0mg/dL -Serum creatinine <=2.0mg/dL 6. Patients with conversion to open thoracotomy. 7. Patients with pulmonary resection range of 2 or more lobes. 8. Patients who cannot drink water within 3 days after surgery.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| CFS (Cancer Fatigue Scale) | — |
Secondary
| Measure | Time frame |
|---|---|
| Breathlessness (VAS), Cancer Dyspnea Scale, MD Anderson Symptom Inventory, Basic Check List (Flail Assessment Tool), Spirometry, Effort Force Capacity, 1 Second Amount, 1 Second Rate, Pulmonary Diffusion Ability, Weight, Blood test | — |
Contacts
Public ContactTakefumi Doi
Kobe University Hospital
Outcome results
None listed